Literature DB >> 25544501

CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.

Zhuting Hu, Michael J Molloy, Edward J Usherwood.   

Abstract

CD4(+) T-cell help (CD4 help) plays a pivotal role in CD8(+) T-cell responses against viral infections. However, the role in primary CD8(+) T-cell responses remains controversial. We evaluated the effects of infection route and viral dose on primary CD8(+) T-cell responses to vaccinia virus (VACV) in MHC class II(-/-) mice. CD4 help deficiency diminished the generation of VACV-specific CD8(+) T cells after intraperitoneal (i.p.) but not after intranasal (i.n.) infection. A large viral dose could not restore normal expansion of VACV-specific CD8(+) T cells in i.p. infected MHC II(-/-) mice. In contrast, dependence on CD4 help was observed in i.n. infected MHC II(-/-) mice when a small viral dose was used. These data suggested that primary CD8(+) T-cell responses are less dependent on CD4 help in i.n. infection compared to i.p. infection. Activated CD8(+) T cells produced more IFN-γ, TNF-α and granzyme B in i.n. infected mice than those in i.p. infected mice, regardless of CD4 help. IL-2 signaling via CD25 was not necessary to drive expansion of VACV-specific CD8(+) T cells in i.n. infection, but it was crucial in i.p. infection. VACV-specific CD8(+) T cells underwent increased apoptosis in the absence of CD4 help, but proliferated normally and had cytotoxic potential, regardless of infection route. Our results indicate that route of infection and viral dose are two determinants for CD4 help dependence, and intranasal infection induces more potent effector CD8(+) T cells than i.p. infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25544501      PMCID: PMC4711678          DOI: 10.1038/cmi.2014.128

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  57 in total

1.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

2.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

Review 3.  Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection.

Authors:  Susan M Kaech; E John Wherry
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

Review 4.  Origin of CD8+ effector and memory T cell subsets.

Authors:  Christian Stemberger; Michael Neuenhahn; Veit R Buchholz; Dirk H Busch
Journal:  Cell Mol Immunol       Date:  2007-12       Impact factor: 11.530

5.  Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses.

Authors:  Elizabeth B Wilson; Alexandra M Livingstone
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

6.  Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.

Authors:  Shinichiro Fuse; Weijun Zhang; Edward J Usherwood
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

7.  Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells.

Authors:  Susan Johnson; Yifan Zhan; Robyn M Sutherland; Adele M Mount; Sammy Bedoui; Jamie L Brady; Emma M Carrington; Lorena E Brown; Gabrielle T Belz; William R Heath; Andrew M Lew
Journal:  Immunity       Date:  2009-02-05       Impact factor: 31.745

Review 8.  The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer.

Authors:  Carmen E Gómez; José L Nájera; Magdalena Krupa; Mariano Esteban
Journal:  Curr Gene Ther       Date:  2008-04       Impact factor: 4.391

9.  Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot study.

Authors:  L Stevceva; E Tryniszewska; Z Hel; J Nacsa; B Kelsall; R Washington Parks; G Franchini
Journal:  BMC Infect Dis       Date:  2001-07-27       Impact factor: 3.090

10.  The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion.

Authors:  Catherine Haluszczak; Adovi D Akue; Sara E Hamilton; Lisa D S Johnson; Lindsey Pujanauski; Lenka Teodorovic; Stephen C Jameson; Ross M Kedl
Journal:  J Exp Med       Date:  2009-02-02       Impact factor: 14.307

View more
  11 in total

1.  The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments In Vivo.

Authors:  Lorena F D de Freitas; Rafael P Oliveira; Mariana C G Miranda; Raíssa P Rocha; Edel F Barbosa-Stancioli; Ana Maria C Faria; Flávio G da Fonseca
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 2.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

3.  Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity.

Authors:  Li-Hao Huang; Elaina M Melton; Haibo Li; Paul Sohn; DaeYoung Jung; Ching-Yi Tsai; Tian Ma; Hiroyuki Sano; HyeKyung Ha; Randall H Friedline; Jason K Kim; Edward Usherwood; Catherine C Y Chang; Ta-Yuan Chang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-13       Impact factor: 4.310

4.  Frontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection.

Authors:  Kai J Rogers; Olena Shtanko; Laura L Stunz; Laura N Mallinger; Tina Arkee; Megan E Schmidt; Dana Bohan; Bethany Brunton; Judith M White; Steve M Varga; Noah S Butler; Gail A Bishop; Wendy Maury
Journal:  J Leukoc Biol       Date:  2020-05-22       Impact factor: 4.962

Review 5.  Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.

Authors:  Jonas D Albarnaz; Alice A Torres; Geoffrey L Smith
Journal:  Viruses       Date:  2018-02-28       Impact factor: 5.048

Review 6.  Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections.

Authors:  Eleni Panagioti; Paul Klenerman; Lian N Lee; Sjoerd H van der Burg; Ramon Arens
Journal:  Front Immunol       Date:  2018-02-16       Impact factor: 7.561

7.  CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.

Authors:  Barbara Bathke; Juliane Pätzold; Ronny Kassub; Raphael Giessel; Kerstin Lämmermann; Maria Hinterberger; Kay Brinkmann; Paul Chaplin; Mark Suter; Hubertus Hochrein; Henning Lauterbach
Journal:  Immunology       Date:  2018-01-26       Impact factor: 7.397

8.  Discordant rearrangement of primary and anamnestic CD8+ T cell responses to influenza A viral epitopes upon exposure to bacterial superantigens: Implications for prophylactic vaccination, heterosubtypic immunity and superinfections.

Authors:  Courtney E Meilleur; Arash Memarnejadian; Adil N Shivji; Jenna M Benoit; Stephen W Tuffs; Tina S Mele; Bhagirath Singh; Jimmy D Dikeakos; David J Topham; Hong-Hua Mu; Jack R Bennink; John K McCormick; S M Mansour Haeryfar
Journal:  PLoS Pathog       Date:  2020-05-20       Impact factor: 6.823

9.  MicroRNA-155 Controls T Helper Cell Activation During Viral Infection.

Authors:  Eliana Goncalves-Alves; Victoria Saferding; Christopher Schliehe; Robert Benson; Mariola Kurowska-Stolarska; Julia Stefanie Brunner; Antonia Puchner; Bruno K Podesser; Josef S Smolen; Kurt Redlich; Michael Bonelli; James Brewer; Andreas Bergthaler; Günter Steiner; Stephan Blüml
Journal:  Front Immunol       Date:  2019-06-13       Impact factor: 7.561

10.  Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection.

Authors:  Hyoung-Shik Shin; Yeonjae Kim; Gayeon Kim; Ji Yeon Lee; Ina Jeong; Joon-Sung Joh; Hana Kim; Eunjin Chang; Soo Yeon Sim; Jun-Sun Park; Dong-Gyun Lim
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.